Pharma Focus Asia
KP - Sustainable Packaging Solutions

TEDOR Pharma, Inc. to Expand its Manufacturing Facility in Cumberland


TEDOR Pharma, Inc. plans to expand its current multi-purpose manufacturing capacity at its facility in Cumberland, Rhode Island.


Several multi-purpose cGMP bays and additional large scale manufacturing equipment are to be installed in the capacity. The new facilities will undergo validation and cGMP qualification prior to its operational startup slated for Q1 2017.

This leads to the enhancement of the large scale manufacturing capabilities of the Cumberland facility, which supports client’s development projects from R&D through to large scale commercial manufacturing.

The multi-million dollar investment facility is adjacent to the 250 acres CVS corporate campus. This manufacturing addition and investment helps to increase the size of the facility. This helps to create expanded capacity and capabilities that are needed for our drug development programs.

The expansion is phase one of an ongoing strategic effort to invest in solid oral dose for both immediate release and modified release formulations that include schedule II controlled substances.


NameTEDOR Pharma, Inc.
LocationCumberland, Rhode Island
Parties InvolvedTEDOR Pharma, Inc.
Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelAsia Healthcare Week 2024Equinix accelerated medical research...CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?